Terms: = Kidney tumors AND NTRK1, ENSG00000198400, 4914, P04629, TRK1, MTC, DKFZp781I14186, p140-TrkA, TRKA, TRK AND Treatment
20 results:
1. Preclinical Evaluation of Minigastrin Analogs and Proof-of-Concept [
Günther T; Holzleitner N; Viering O; Beck R; Wienand G; Dierks A; Pfob CH; Bundschuh RA; Kircher M; Lapa C; Wester HJ
J Nucl Med; 2024 Jan; 65(1):33-39. PubMed ID: 37945383
[TBL] [Abstract] [Full Text] [Related]
2. Peptide Receptor Radionuclide Therapy in Thyroid Cancer.
Gubbi S; Koch CA; Klubo-Gwiezdzinska J
Front Endocrinol (Lausanne); 2022; 13():896287. PubMed ID: 35712243
[TBL] [Abstract] [Full Text] [Related]
3. Mesenchymal neoplasms with Ntrk and other kinase gene alterations.
Davis JL; Al-Ibraheemi A; Rudzinski ER; Surrey LF
Histopathology; 2022 Jan; 80(1):4-18. PubMed ID: 34958503
[TBL] [Abstract] [Full Text] [Related]
4. Ntrk-Rearranged soft tissue neoplasms: A review of evolving diagnostic entities and algorithmic detection methods.
Surrey LF; Davis JL
Cancer Genet; 2022 Jan; 260-261():6-13. PubMed ID: 34794069
[TBL] [Abstract] [Full Text] [Related]
5. Effects of Tyrosine Kinase Inhibitors on Blood Pressure in Patients with Unresectable or Advanced Recurrent Renal Cell Carcinoma-Bayes-Mixed treatment Comparison Meta-Analysis.
Yamaguchi S; Murayama R; Satoh E; Inoue T; Ise Y
Gan To Kagaku Ryoho; 2021 Sep; 48(9):1145-1151. PubMed ID: 34521793
[TBL] [Abstract] [Full Text] [Related]
6. Updates on the Management of Thyroid Cancer.
Araque KA; Gubbi S; Klubo-Gwiezdzinska J
Horm Metab Res; 2020 Aug; 52(8):562-577. PubMed ID: 32040962
[TBL] [Abstract] [Full Text] [Related]
7. Cholecystokinin 2 Receptor Agonist
Rottenburger C; Nicolas GP; McDougall L; Kaul F; Cachovan M; Vija AH; Schibli R; Geistlich S; Schumann A; Rau T; Glatz K; Behe M; Christ ER; Wild D
J Nucl Med; 2020 Apr; 61(4):520-526. PubMed ID: 31519804
[TBL] [Abstract] [Full Text] [Related]
8. trk inhibitor GNF‑5837 suppresses the tumor growth, survival and migration of renal cell carcinoma.
Chen Y; Wang H; Chen Y; Wang M; Ding G; Li T
Oncol Rep; 2019 Nov; 42(5):2039-2048. PubMed ID: 31485624
[TBL] [Abstract] [Full Text] [Related]
9. Axitinib, cabozantinib, everolimus, nivolumab, sunitinib and best supportive care in previously treated renal cell carcinoma: a systematic review and economic evaluation.
Edwards SJ; Wakefield V; Cain P; Karner C; Kew K; Bacelar M; Masento N; Salih F
Health Technol Assess; 2018 Jan; 22(6):1-278. PubMed ID: 29393024
[TBL] [Abstract] [Full Text] [Related]
10. [Cabozantinib: Mechanism of action, efficacy and indications].
Cochin V; Gross-Goupil M; Ravaud A; Godbert Y; Le Moulec S
Bull Cancer; 2017 May; 104(5):393-401. PubMed ID: 28477875
[TBL] [Abstract] [Full Text] [Related]
11. Long-Term Follow-Up and treatment of Postoperative Permanent Hypoparathyroidism in Patients with Medullary Thyroid Carcinoma: Differences in Complete and Partial Disease.
Leidig-Bruckner G; Bruckner T; Raue F; Frank-Raue K
Horm Metab Res; 2016 Dec; 48(12):806-813. PubMed ID: 27813050
[TBL] [Abstract] [Full Text] [Related]
12. From preclinical development to clinical application: Kit formulation for radiolabelling the minigastrin analogue CP04 with In-111 for a first-in-human clinical trial.
Pawlak D; Rangger C; Kolenc Peitl P; Garnuszek P; Maurin M; Ihli L; Kroselj M; Maina T; Maecke H; Erba P; Kremser L; Hubalewska-Dydejczyk A; Mikołajczak R; Decristoforo C
Eur J Pharm Sci; 2016 Mar; 85():1-9. PubMed ID: 26826279
[TBL] [Abstract] [Full Text] [Related]
13. Tyrosine receptor kinase B silencing inhibits anoikis‑resistance and improves anticancer efficiency of sorafenib in human renal cancer cells.
Zhang P; Xing Z; Li X; Song Y; Zhao J; Xiao Y; Xing Y
Int J Oncol; 2016 Apr; 48(4):1417-25. PubMed ID: 26820170
[TBL] [Abstract] [Full Text] [Related]
14. [Clinical outcomes after non-ischemic partial nephrectomy for clinical T1 renal tumors using soft coagulation versus microwave tissue coagulation].
Sumiyoshi T; Kohno J; Maeno A; Iwamura H; Mitsumori K; Nishimura K
Nihon Hinyokika Gakkai Zasshi; 2014 Jul; 105(3):85-90. PubMed ID: 25158549
[TBL] [Abstract] [Full Text] [Related]
15. Development of a calcium-sensing receptor molecular imaging agent.
Yusof AM; Kothandaraman S; Zhang X; Saji M; Ringel MD; Tweedle MF; Phay JE
Surgery; 2013 Dec; 154(6):1378-84; discussion 1384. PubMed ID: 24238055
[TBL] [Abstract] [Full Text] [Related]
16. In vitro transforming potential, intracellular signaling properties, and sensitivity to a kinase inhibitor (sorafenib) of RET proto-oncogene variants Glu511Lys, Ser649Leu, and Arg886Trp.
Prazeres H; Couto JP; Rodrigues F; Vinagre J; Torres J; Trovisco V; Martins TC; Sobrinho-Simões M; Soares P
Endocr Relat Cancer; 2011 Aug; 18(4):401-12. PubMed ID: 21551259
[TBL] [Abstract] [Full Text] [Related]
17. [Partial nephrectomy for renal cell carcinoma using a microwave tissue coagulator--postoperative recurrence and renal function].
Fujimoto K; Tanaka N; Hirao Y
Hinyokika Kiyo; 2005 Aug; 51(8):511-5. PubMed ID: 16164265
[TBL] [Abstract] [Full Text] [Related]
18. K252a inhibits the oncogenic properties of Met, the HGF receptor.
Morotti A; Mila S; Accornero P; Tagliabue E; Ponzetto C
Oncogene; 2002 Jul; 21(32):4885-93. PubMed ID: 12118367
[TBL] [Abstract] [Full Text] [Related]
19. [Expression of the neurotrophin-receptor trkB predicts outcome in nephroblastomas: results of a pilot-study].
Eggert A; Grotzer MA; Zhao H; Brodeur GM; Evans AE
Klin Padiatr; 2001; 213(4):191-6. PubMed ID: 11528553
[TBL] [Abstract] [Full Text] [Related]
20. Radiopeptide transmitted internal irradiation of non-iodophil thyroid cancer and conventionally untreatable medullary thyroid cancer using.
Waldherr C; Schumacher T; Pless M; Crazzolara A; Maecke HR; Nitzsche EU; Haldemann A; Mueller-Brand J
Nucl Med Commun; 2001 Jun; 22(6):673-8. PubMed ID: 11403179
[TBL] [Abstract] [Full Text] [Related]
